Welcome to the ECCMID 2021 programme page. 
We inform you that times mentioned on the programme refer to Central European Summer Time (CEST). Please make sure to take this into account when planning your attendance to the event. 

Please find below the colour code:

• Orange: Educational Workshops, Meet-the-Expert Sessions
• Green: Integrated Symposia
• Light blue: Symposia
• Dark blue: Keynote Lectures
• Grey: Special Sessions
• Pink: Oral Sessions

previous daynext daytoday

• Day
• Week
• Timeline

09 July 2021

	1. Viral infections 2. Bacterial infection 3. Antimicrobial resistance 4. Diagnostics 5. Antimicrobials & stewardship 6. Fungal infections 7. Parasites & international health 8. Infection prevention & control 9. Basic microbiology 10. Immunology & vaccinology 11. Special sessions & Other 12. COVID-19 13. Integrated sessions - 1 14. Integrated Sessions – 2 15. Integrated Sessions – 3 16. Integrated Sessions – 4 17. Integrated Sessions – 5
all day
08:00           09:00           10:00           11:00           12:00           13:00           14:00           15:00           16:00           17:00           18:00           19:00           20:00	2648 • Hot topics in HIV infection 1. Viral infection & disease 1,5-hour Symposium 1a. HIV/AIDS (incl diagnostics & epidemiology, anti-retroviral drugs, vaccines, treatment & susceptibility/resistance) Hot topics in HIV infection S26 • Updates from patients with bacterial infection from the time of COVID-19 to the time of the Black Death 2. Bacterial infection & disease 1-hour Oral Case Session Updates from patients with bacterial infection from the time of COVID-19 to the time of the Black Death 2166 • Antimicrobial susceptibility testing with EUCAST methods and breakpoints 3. Bacterial susceptibility & resistance 2,5-hour Educational Workshop 3c. Susceptibility testing methods (incl assay validation and comparative studies, excl TB) Antimicrobial susceptibility testing with EUCAST methods and breakpoints 2645 • Multiplexed diagnostic panels: benefits, pitfalls and clinical applicability 4. Diagnostic bacteriology & general microbiology Meet-the-Expert Session 4d. Molecular diagnostics (incl POCT and syndromic testing) Multiplexed diagnostic panels: benefits, pitfalls and clinical applicability S30 • Antimicrobial stewardship in children 5. New antibacterial agents, PK/PD & Stewardship 30min ePoster Review Antimicrobial stewardship in children 2183 • Improving the impact of fungal diagnostic tests on patient management 6. Fungal infection & disease 1-hour Symposium 6b. Diagnostic mycology (incl molecular) Improving the impact of fungal diagnostic tests on patient management S24 • Malaria: diagnosis and resistance 7. Parasitic diseases & international health 1-hour Oral Session Malaria: diagnosis and resistance S82 • Reducing the burden of transmissions 8. Healthcare-associated & nosocomial infections, infection control 1-hour Oral Session Reducing the burden of transmissions   S8 • Advances in understanding immune responses to important human pathogens 10. Immunology & vaccinology 1-hour Mini Oral Flash Advances in understanding immune responses to important human pathogens   S56 • COVID-19 and thromboembolic disease 12. COVID-19 1-hour Oral Session COVID-19 and thromboembolic disease                                                                                                   2619 • Medical guidelines development during and after the pandemic 11. Other 1,5-hour Educational Workshop 11b. Publishing, ethics, other academic and professional affairs Medical guidelines development during and after the pandemic                                                                                   2620 • Guidelines on Nontuberculous mycobacterial pulmonary disease 2. Bacterial infection & disease Meet-the-Expert Session 2a. Tuberculosis and other mycobacterial infections (incl antimycobacterial drugs, treatment & susceptibility/resistance, diagnostics & epidemiology) Guidelines on Nontuberculous mycobacterial pulmonary disease   2205 • How to implement NGS into routine clinical diagnostics and microbial typing? 4. Diagnostic bacteriology & general microbiology Meet-the-Expert Session 4f. Whole genome sequencing (diagnostic, typing) How to implement NGS into routine clinical diagnostics and microbial typing? S11 • Innovative PK/PD approaches to improve dosing 5. New antibacterial agents, PK/PD & Stewardship 1-hour Mini Oral Flash Innovative PK/PD approaches to improve dosing S222 • Mycology from bench to bedside 6. Fungal infection & disease 1-hour ePoster Review Mycology from bench to bedside S61 • Contemporary issues in the diagnosis of parasitic infections 7. Parasitic diseases & international health 1-hour ePoster Review Contemporary issues in the diagnosis of parasitic infections         S125 • COVID-19 across healthcare systems 12. COVID-19 1-hour Mini Oral Flash COVID-19 across healthcare systems                                                                                                                                                                                                                       S110 • HIV infection: clinical considerations 1. Viral infection & disease 1,5-hour Oral Session HIV infection: clinical considerations 2229 • Prevention of endocarditis 2. Bacterial infection & disease 1,5-hour Educational Workshop 2b. Severe sepsis, bacteraemia & endocarditis (incl host bio-markers) Prevention of endocarditis   S53 • Machine learning, artificial intelligence and novel applications in diagnostic microbiology 4. Diagnostic bacteriology & general microbiology 1-hour Mini Oral Flash Machine learning, artificial intelligence and novel applications in diagnostic microbiology S48 • Multidisciplinary science underpins antimicrobial stewardship 5. New antibacterial agents, PK/PD & Stewardship 1,5-hour Oral Session Multidisciplinary science underpins antimicrobial stewardship   S81 • Parasites full of surprises 7. Parasitic diseases & international health 1,5-hour Case Session Parasites full of surprises 2343 • How to implement effective antimicrobial stewardship linked to infection prevention 8. Healthcare-associated & nosocomial infections, infection control 1,5-hour Educational Workshop 8g. Infection control interventions and trials (incl. microbiota transplantation) How to implement effective antimicrobial stewardship linked to infection prevention 2479 • Looking deeper into the microbiota 9. Experimental microbiology, microbial pathogenesis & biofilm 1,5-hour Symposium 9b. Host-pathogen interaction (including basic microbiome studies) Looking deeper into the microbiota   2685 • Year in Infectious Diseases 11. Other 1-hour Symposium 11c. Other Year in Infectious Diseases S91 • COVID-19 in high risk patient populations 12. COVID-19 1,5-hour Oral Session COVID-19 in high risk patient populations                                                                                         2146 • Candida auris and global health aspects 6. Fungal infection & disease 1-hour Symposium <em>Candida auris</em> and global health aspects                                                                                                                                                                                                                                                                                                                                                                                                             2559 • From bats to environmental change: a One Health approach to pandemic preparedness 1. Viral infection & disease 1-hour Symposium 1e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (all aspects)/resistance, excl clinical studies in immunocompromised hosts) From bats to environmental change: a One Health approach to pandemic preparedness 2364 • Molecular testing for genital mycoplasmas and ureaplasmas in asymptomatic individuals 2. Bacterial infection & disease 1-hour Symposium 2e. Skin, soft tissue, bone & joint (excl prostheses) & central nervous system infections Molecular testing for genital mycoplasmas and ureaplasmas in asymptomatic individuals 2347 • The immune system of bacteria: CRISPR and beyond 3. Bacterial susceptibility & resistance Keynote Lecture 3d. Resistance mechanisms (excl TB) The immune system of bacteria: CRISPR and beyond     S103 • News in the antifungal world: new drugs and resistance mechanisms 6. Fungal infection & disease 1-hour Oral Session News in the antifungal world: new drugs and resistance mechanisms         2664 • Young Investigator Award lectures 11. Other Special Session 11c. Other Young Investigator Award lectures S57 • Pathophysiology of COVID-19 12. COVID-19 1-hour Oral Session Pathophysiology of COVID-19 2692 • Revising the paradigm: the importance of adult vaccination against respiratory diseases 11. Other 2-hour Integrated Symposium 11c. Other Revising the paradigm: the importance of adult vaccination against respiratory diseases 2788 • The challenges of managing the COVID-19 pandemic from pre-analytic to diagnosis 11. Other 1-hour Integrated Symposium 11c. Other The challenges of managing the COVID-19 pandemic from pre-analytic to diagnosis 2789 • Viruses mutate, and SARS-CoV-2 is no exception. Emerging mutation surveillance and confirmation 11. Other 2-hour Integrated Symposium 11c. Other Viruses mutate, and SARS-CoV-2 is no exception. Emerging mutation surveillance and confirmation   3220 • Spotlight on COVID-19: where are we now? 11. Other 2-hour Integrated Symposium 11c. Other Spotlight on COVID-19: where are we now?                                                                                                                                                                           S105 • Epidemiology of HIV infection 1. Viral infection & disease 1-hour Oral Session Epidemiology of HIV infection S59 • Urinary and genital infections: what is new? 2. Bacterial infection & disease 1-hour Oral Session Urinary and genital infections: what is new? S23 • Novel findings in resistance mechanisms 3. Bacterial susceptibility & resistance 1-hour ePoster Review Novel findings in resistance mechanisms S111 • Diagnostic value of metagenomics 4. Diagnostic bacteriology & general microbiology 1-hour Oral Session Diagnostic value of metagenomics 2662 • Public Health approach to integrated antimicrobial stewardship: what needs to be done 5. New antibacterial agents, PK/PD & Stewardship Keynote Lecture 5f. Other Public Health approach to integrated antimicrobial stewardship: what needs to be done 2531 • Fungal mycobiota in beach sand and water: relevance to public health 6. Fungal infection & disease 1-hour Symposium 6e. Other Fungal mycobiota in beach sand and water: relevance to public health     2480 • Biofilms as hot spots for the development and transmission of antimicrobial resistance 9. Experimental microbiology, microbial pathogenesis & biofilm 1-hour Symposium 9a. Microbial pathogenesis & virulence Biofilms as hot spots for the development and transmission of antimicrobial resistance     S113 • Epidemiology of COVID-19 around the world 12. COVID-19 1-hour Mini Oral Flash Epidemiology of COVID-19 around the world       2795 • Developing new vaccines to protect against infectious diseases at home and abroad 11. Other 1-hour Integrated Symposium 11c. Other Developing new vaccines to protect against infectious diseases at home and abroad                                                                                                                                                                                                     2797 • How the pandemic changed the pathway of diagnosis of infectious diseases: rapid diagnostic solutions for COVID-19 11. Other 1-hour Integrated Symposium 11c. Other How the pandemic changed the pathway of diagnosis of infectious diseases: rapid diagnostic solutions for COVID-19                                           S117 • Emerging vector-borne and zoonotic viruses 1. Viral infection & disease 1,5-hour Oral Session Emerging vector-borne and zoonotic viruses 2654 • Challenges of treating bacterial infections in elderly patients 2. Bacterial infection & disease 1,5-hour Symposium 2b. Severe sepsis, bacteraemia & endocarditis (incl host bio-markers) Challenges of treating bacterial infections in elderly patients 2656 • Success stories of antibiotic resistance plasmids 3. Bacterial susceptibility & resistance 1,5-hour Symposium 3g. Spread of resistance incl reservoirs, ecology, mobile elements (excl nosocomial transmission) Success stories of antibiotic resistance plasmids 2396 • The gut microbiome: not only bacteria, but also parasites and fungi! 4. Diagnostic bacteriology & general microbiology 1,5-hour Symposium 4g. Microbiome studies (incl clinical and diagnostic studies, One Health aspects) The gut microbiome: not only bacteria, but also parasites and fungi! S22 • New modalities for improving antimicrobial stewardship 5. New antibacterial agents, PK/PD & Stewardship 1-hour Oral Session New modalities for improving antimicrobial stewardship     2547 • Research on diagnosis and antimicrobial treatment of biofilm-related bone and prosthetic joint infections 8. Healthcare-associated & nosocomial infections, infection control 1,5-hour Symposium 8b. Other foreign-body and implant infections Research on diagnosis and antimicrobial treatment of biofilm-related bone and prosthetic joint infections   S31 • Immunisation policies for bacterial and viral diseases 10. Immunology & vaccinology 30min ePoster Review Immunisation policies for bacterial and viral diseases 2773 • WHO panel discussion - Narrowing the gap between research and policy 5. New antibacterial agents, PK/PD & Stewardship Special Session 5f. Other WHO panel discussion - Narrowing the gap between research and policy S78 • COVID-19: clinical diagnostics 12. COVID-19 1,5-hour Oral Session COVID-19: clinical diagnostics                                                                                                                                         2762 • Importance of influenza vaccination in the COVID-19 environment 11. Other 2-hour Integrated Symposium 11c. Other Importance of influenza vaccination in the COVID-19 environment 2711 • Superbugs, Susceptibility & Stewardship: with more antibiotics available for multidrug-resistant Gram-negative bacterial infections, what's holding us back? 11. Other 2-hour Integrated Symposium 11c. Other Superbugs, Susceptibility & Stewardship: with more antibiotics available for multidrug-resistant Gram-negative bacterial infections, what's holding us back? 2694 • Deciphering the data: clinical impact of vaccines and monoclonal antibodies for COVID-19 11. Other 2-hour Integrated Symposium 11c. Other Deciphering the data: clinical impact of vaccines and monoclonal antibodies for COVID-19 2696 • The role of patients in infectious disease research: from study participants to scientific partners 11. Other 1,5-hour Integrated Symposium 11c. Other The role of patients in infectious disease research: from study participants to scientific partners                                                                                                                                                                             2598 • Congenital CMV infection: state-of-the-art approach to diagnostics and treatment 1. Viral infection & disease Meet-the-Expert Session 1d. Herpesviruses (incl diagnostics & epidemiology, antiviral drugs, treatment & susceptibility/resistance, excl clinical studies in immunocompromised hosts) Congenital CMV infection: state-of-the-art approach to diagnostics and treatment S5 • Paediatric bloodstream infections: from neonates to children 2. Bacterial infection & disease 1-hour Mini Oral Flash Paediatric bloodstream infections: from neonates to children     2274 • MDR efflux: from basic science to efflux inhibitors 5. New antibacterial agents, PK/PD & Stewardship Keynote Lecture 5d. Pharmacoepidemiology (incl economics and cost-effectiveness), improved prescribing and antibiotic stewardship (incl decision-support / prediction tools, behavioural aspects) MDR efflux: from basic science to efflux inhibitors       S80 • Perturbance of established microbial communities 9. Experimental microbiology, microbial pathogenesis & biofilm 1-hour Oral Session Perturbance of established microbial communities   2686 • Year in Infection Control 11. Other 1-hour Symposium 11c. Other Year in Infection Control 2756 • Limiting the lung damage of critically ill ventilated COVID-19 patients 12. COVID-19 1-hour Symposium 12c. Clinical features, case management, outcome Limiting the lung damage of critically ill ventilated COVID-19 patients                                                                                                                                                                                                                                                                                                                                                                                                 S116 • Viral respiratory infections: not only COVID 1. Viral infection & disease 1,5-hour Oral Session Viral respiratory infections: not only COVID 2372 • Controversies in the management of sepsis in the solid organ transplant patient 2. Bacterial infection & disease 1,5-hour Educational Workshop 2b. Severe sepsis, bacteraemia & endocarditis (incl host bio-markers) Controversies in the management of sepsis in the solid organ transplant patient S76 • New insights into emergence and spread of AMR Klebsiella pneumoniae 3. Bacterial susceptibility & resistance 1,5-hour Oral Session New insights into emergence and spread of AMR <em>Klebsiella pneumoniae</em>   S3 • Antimicrobial utilisation in COVID times 5. New antibacterial agents, PK/PD & Stewardship 1-hour Mini Oral Flash Antimicrobial utilisation in COVID times 2319 • What's new with dermatophytes? 6. Fungal infection & disease 1,5-hour Symposium 6a. Fungal disease epidemiology What's new with dermatophytes? 2302 • New spatial approaches for studying global health 7. Parasitic diseases & international health 1,5-hour Educational Workshop 7g. International & public health New spatial approaches for studying global health S75 • Novel insights and interventions to reduce healthcare-associated infections 8. Healthcare-associated & nosocomial infections, infection control 1,5-hour Oral Session Novel insights and interventions to reduce healthcare-associated infections 2556 • Building and destroying a biofilm 9. Experimental microbiology, microbial pathogenesis & biofilm 1,5-hour Educational Workshop 9a. Microbial pathogenesis & virulence Building and destroying a biofilm 2666 • Update on new vaccines 10. Immunology & vaccinology 1,5-hour Symposium 10g. Other Update on new vaccines   S100 • COVID-19 vulnerability and the socially disadvantaged 12. COVID-19 1,5-hour Oral Session COVID-19 vulnerability and the socially disadvantaged

Please note that times mentioned on the programme refer to Central European Summer Time (CEST).